Atezolizumab,Bevacizumab,Nivolumab,Ipilimumab,celecoxib,BMS-986253,BMS-986016
Roche,BMS,Pfizer
['niche,(-niche 2),(-niche-2),(-niche2)']
 maybe think about i/o in stage ii &amp; iii patients or in novel interventions in mrd trials. the tarzan trial of dr builds on results from niche1 trial with 26% of mss patients having benefit. asco even has an abstract about it!
volunteer #CRCSM librarian
#BRAF & #NRAS FB grps
Stage 4 CRC Support & Colon Cancer Stars
trials Stage 2/3 pts
https://t.co/48vU5493pH